Bile duct cancer detection, DiaPat BPA-CC test (bile)

Bile duct cancer detection, DiaPat BPA-CC test (bile)

850.00 €

umsatzsteuerbefreit nach §4 Nr.14a UStG plus delivery
Product data sheet
In stock
Delivery time: 2-3 day(s)

Description

Price only on request.


Ordering this test is reserved exclusively for specialist clinics.

Please get in touch with us.


BPA-CC test (bile)

Inflammation of the bile ducts can have various causes, such as blockage or narrowing of the bile ducts, but also tumors. To find out what the cause is, an endoscopic examination is usually carried out, the so-called ERCP (endoscopic retrograde cholangiopancreatography), in which a special endoscope is advanced through the stomach into the bile ducts. Bile is also extracted during this examination. The DiaPat® BPA-CC test can be used to complement invasive ERCP. The test also enables a more precise diagnosis in the case of an unclear suspicion of bile duct cancer.



  • Early detection of bile duct cancer
  • Take a urine sample at home - simple + discreet
  • CE-compliant laboratory diagnostics
  • High analytical accuracy
  • Clinically tested
  • Result within 2-3 working days after sample receipt